What is the difference between glycogen and glucagon in peptide products?
Abstract: Glycogen (a branched polysaccharide) and glucagon (a 29-amino-acid peptide hormone) are fundamentally distinct in peptide products. Glucagon is a bioactive peptide used in diabetes therapeutics and diagnostics, while glycogen serves as a carbohydrate excipient. Market trends show rising demand for synthetic glucagon analogs (e.g., nasal powder, injectable pens) driven by hypoglycemia management, with key brands like GlucaGen and Baqsimi. Technically, glucagon offers rapid glucose mobilization but suffers from instability; glycogen provides inert bulk but no bioactivity. Product parameters differ: glucagon purity >98% (HPLC), glycogen molecular weight 10⁶–10⁷ Da. Industry data (Grand View Research, 2024) projects a 7.2% CAGR for peptide therapeutics. Selection requires verifying GMP certification, stability data, and cold-chain logistics (2–8°C for glucagon).